Streetbeat News

Stock Prices

GOSS

Trading halt status was updated at 7:55:00 AM ET, indicating a quotation resumption for GOSS.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:55 am

CMMB

Oppenheimer analyst Jeff Jones upgrades Chemomab Therapeutics (CMMB) from Perform to Outperform with a $6 price target.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:52 am

LYRA

Trading on LYRA was halted at 7:50:00 a.m. ET due to pending news. This action indicates that significant news is expected to be released, which could materially affect the company's stock price.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:50 am

OMH

Ohmyhome's stock price has increased following the announcement that the company received a Nasdaq deficiency notice.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:44 am

OMH

Ohmyhome Limited received a Nasdaq deficiency notice due to its share price falling below the $1.00 minimum requirement for 30 consecutive days. The company has 180 days, until October 28, 2024, to regain compliance. If unsuccessful, it may receive an extension or face delisting. Ohmyhome intends to explore options to address the issue.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:41 am

ARKB

BITB

FBTC

GBTC

IBIT

Bitcoin spot ETFs in the U.S. saw a significant rebound with $378M in inflows on May 3rd, marking a shift from recent outflows. The Grayscale Bitcoin Trust (GBTC), Fidelity Bitcoin Trust (FBTC), BlackRock's iShares Bitcoin Trust (IBIT), Bitwise's Bitcoin ETF (BITB), and Ark's ETF (ARKB) all experienced notable inflows. This resurgence in investment coincides with a recovery in the crypto market and broader economic signals suggesting easing inflation, potentially influencing Federal Reserve policies.

Portfolio Pulse from Murtuza Merchant

May 06, 2024 | 11:40 am

TSN

Tyson Foods shares are trading higher after the company reported mixed Q2 earnings, indicating a positive market reaction despite the mixed financial results.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:40 am

BOWL

Bowlero (NYSE:BOWL) reported Q3 sales of $337.670 million, missing the analyst consensus estimate of $341.414 million by 1.10%. This represents a 6.95% increase over the same period last year.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:39 am

EYPT

EyePoint Pharmaceuticals' shares dropped following the announcement that its Phase 2 PAVIA trial of DURAVYU failed to meet its primary endpoint.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:39 am

DKNG

BTIG analyst Clark Lampen maintains a Buy rating on DraftKings (NASDAQ:DKNG) and raises the price target from $53 to $55.

Portfolio Pulse from Benzinga Newsdesk

May 06, 2024 | 11:39 am